CIK 0001742927 · Non-accelerated filer<br>Smaller reporting company
REVIVA PHARMACEUTICALS HOLDINGS, INC.
Sign in to watch- Ticker
- RVPH
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 4085018881
- Business address
- 10080 N WOLFE ROAD, SUITE SW3-200, CUPERTINO, CA, 95014
- Former names
- Tenzing Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-18 | Prabhu Narayan Chief Financial Officer | Grant or award · Stock Option (right to buy) | +40,925 | 40,925 | ||
| 2026-03-18 | Bhat Laxminarayan President and CEO | Grant or award · Stock Option (right to buy) | +109,150 | 109,150 | ||
| 2026-03-18 | Bhat Laxminarayan President and CEO | Grant or award · Stock Option (right to buy) | +40,925 | 40,925 | ||
| 2025-12-18 | Funtleyder Leslie D. Director | Grant or award · Stock Option (right to buy) | +8,200 | 8,200 | ||
| 2025-12-18 | Margolin Richard A Director | Grant or award · Stock Option (right to buy) | +8,200 | 8,200 | ||
| 2025-12-18 | Patel Purav Director | Grant or award · Stock Option (right to buy) | +8,200 | 8,200 | ||
| 2025-12-18 | SAXENA PARAG Director | Grant or award · Stock Option (right to buy) | +8,200 | 8,200 | ||
| 2025-02-13 | Narayan Prabhu Chief Financial Officer | Grant or award · Stock Option (right to buy) | +194,250 | 194,250 | ||
| 2025-02-13 | Bhat Laxminarayan President and CEO | Grant or award · Stock Option (right to buy) | +519,000 | 519,000 | ||
| 2025-02-13 | Bhat Laxminarayan President and CEO | Grant or award · Stock Option (right to buy) | +181,500 | 181,500 | ||
| 2024-12-10 | Patel Purav Director | Grant or award · Stock Option (right to buy) | +8,200 | 8,200 | ||
| 2024-12-10 | SAXENA PARAG Director | Grant or award · Stock Option (right to buy) | +8,200 | 8,200 | ||
| 2024-12-10 | Funtleyder Leslie D. Director | Grant or award · Stock Option (right to buy) | +8,200 | 8,200 | ||
| 2024-12-10 | Margolin Richard A Director | Grant or award · Stock Option (right to buy) | +8,200 | 8,200 | ||
| 2024-09-15 | Bhat Laxminarayan President and CEO | Grant or award · Stock Option (right to buy) | +158,451 | 158,451 | ||
| 2024-09-15 | Bhat Laxminarayan President and CEO | Grant or award · Stock Option (right to buy) | +77,843 | 77,843 | ||
| 2024-09-15 | Narayan Prabhu Chief Financial Officer | Grant or award · Stock Option (right to buy) | +96,519 | 96,519 | ||
| 2023-11-20 | SAXENA PARAG Director | Other acquisition · Pre-Funded Warrant | +585,366 | 585,366 | ||
| 2023-11-20 | SAXENA PARAG Director | Other acquisition · Common Stock Warrant (right to buy) | +585,366 | 585,366 | ||
| 2023-11-13 | Funtleyder Leslie D. Director | Grant or award · Stock Option (right to buy) | +8,200 | 8,200 |
Page 1 of 5 · 83 trades